Onward Medical N.V.
Develops neurostimulation therapies to restore function for people with spinal cord injury.
ONWD | AS
Overview
Corporate Details
- ISIN(s):
- NL0015000HT4
- LEI:
- 9845007A2CC4C8BFSB80
- Country:
- Netherlands
- Address:
- Schimmelt 2, 5611ZX Eindhoven
- Website:
- https://www.onwd.com/
- Sector:
- Manufacturing
Description
Onward Medical is a neurotechnology company that develops therapies to restore movement, function, and independence for people with spinal cord injury (SCI). The company's commercial product, the ARC-EX System, is an external, non-invasive spinal cord stimulation therapy indicated to improve hand sensation and strength for individuals with chronic cervical SCI. The system is used in rehabilitation clinics and is also cleared for home use. Onward Medical is also advancing its investigational implantable platform, the ARC-IM System, which is designed to address other functional deficits, including blood pressure regulation, following spinal cord injury.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-25 08:23 |
ONWARD® Medical Publishes Prospectus for Listing of New Shares
|
English | PDF • 115.4 KB | ||
| 2024-10-24 17:45 |
ONWARD® Medical Publishes Prospectus for Listing of New Shares
|
English | PDF • 115.4 KB | ||
| 2024-10-24 07:41 |
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increa…
|
English | PDF • 131.4 KB | ||
| 2024-10-24 07:30 |
ONWARD® Medical Successfully Raises EUR 50 Million in an Upsized Capital Increa…
|
English | PDF • 131.4 KB | ||
| 2024-10-23 09:00 |
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Mi…
|
English | PDF • 153.8 KB | ||
| 2024-10-22 17:45 |
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Mi…
|
English | PDF • 153.8 KB | ||
| 2024-10-15 07:41 |
ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIM…
|
English | PDF • 168.1 KB | ||
| 2024-10-15 07:31 |
ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs d…
|
French | PDF • 203.8 KB | ||
| 2024-09-10 08:23 |
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
|
English | PDF • 151.4 KB | ||
| 2024-09-10 07:32 | English | PDF • 9.0 MB | |||
| 2024-07-01 07:31 |
Press Release - ONWARD Medical N.V. Obtains Debt Financing (28 June 2024)
|
English | PDF • 224.4 KB | ||
| 2024-06-14 07:50 |
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
|
English | PDF • 96.8 KB | ||
| 2024-05-21 08:01 |
Nature Medicine Highlights Significant Improvement in Hand and Arm Function Aft…
|
English | PDF • 139.3 KB | ||
| 2024-05-02 07:47 |
Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Res…
|
English | PDF • 171.9 KB | ||
| 2024-04-25 07:41 |
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shar…
|
English | PDF • 135.2 KB |
Automate Your Workflow. Get a real-time feed of all Onward Medical N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Onward Medical N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Onward Medical N.V. via our API.
Peer Companies
